New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 26, 2012
10:00 EDTALKS, MDCO, BCEI, DKS, VAR, CBRL, ARIA, ARQLOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: ARIAD (ARIA) initiated with a Buy at Citigroup... Alkermes (ALKS) initiated with a Buy at Citigroup... ArQule (ARQL) initiated with a Buy at Citigroup... Bonanza Creek Energy (BCEI) initiated with a Buy at SunTrust... Dick's Sporting (DKS) initiated with a Market Perform at BMO Capital... The Medicines Co. (MDCO) initiated with a Neutral at Citigroup... Varian Medical (VAR) initiated with a Buy at Brean Capital... Cracker Barrel (CBRL) initiated with a Buy at CL King.
News For ARIA;ARQL;ALKS;MDCO;BCEI;DKS;VAR;CBRL From The Last 14 Days
Check below for free stories on ARIA;ARQL;ALKS;MDCO;BCEI;DKS;VAR;CBRL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2014
07:27 EDTVARVarian Medical weakness should be bought, says Brean Capital
Subscribe for More Information
April 23, 2014
16:26 EDTVARVarian Medical sees Q3 EPS $1.06-$1.10, consensus $1.13
Subscribe for More Information
16:25 EDTVARVarian Medical backs 2014 EPS view $4.06-$4.18, consensus $4.30
Subscribe for More Information
16:24 EDTVARVarian Medical reports Q2 EPS 88c with charges, consensus $1.03
Subscribe for More Information
11:48 EDTCBRLCracker Barrel holders reject Biglari’s proposals at special meeting
Subscribe for More Information
07:22 EDTMDCOThe Medicines Co. to acquire Tenaxis for $58M
The Medicines Company and Tenaxis Medical announced an agreement for The Medicines Company to acquire Tenaxis. Tenaxis's sole product, which mechanically seals both human tissue and artificial grafts is approved, but not launched in the US -- having received U.S. PMA approval from the FDA in March 2013 as a vascular sealant. The product is also approved with a European CE Mark as a surgical sealant applicable to cardiovascular, general, urological, and thoracic surgery. Under the terms of the agreement, The Medicines Company will pay $58M upfront on closing of the deal. The Medicines Company will also pay milestone payments of up to $112M contingent upon achieving certain commercial and -- in pursuit of even broader indications -- regulatory approval milestones.
07:08 EDTMDCOThe Medicines Co. reports Q1 adjusted EPS 33c, may not compare to consensus (7c)
Subscribe for More Information
April 22, 2014
07:43 EDTARIAARIAD has reached compelling entry point, says Stifel
Subscribe for More Information
April 17, 2014
16:35 EDTALKSAlkermes recent pullback a buying opportunity, says Leerink
Leerink does not expect any surprises when Alkermes reports Q1 results and views the recent pullback in shares as a buying opportunity. The firm reiterates an Outperform rating on the stock with a $66 price target.
09:59 EDTMDCOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:55 EDTCBRLCracker Barrel to host special shareholder meeting
Subscribe for More Information
07:17 EDTMDCOThe Medicines Co. downgraded to Market Perform from Outperform at Leerink
Subscribe for More Information
April 15, 2014
07:22 EDTBCEIGlobal Hunter Securities to hold a conference
1:1 Dallas Energy Day is being held in Dallas on April 15.
April 14, 2014
11:05 EDTCBRLCracker Barrel says proxy advisors recommend voting against Biglari proposals
Earlier today, Cracker Barrel Old Country Store announced that Institutional Shareholder Services, ISS, Glass, Lewis and Egan-Jones Proxy Services have unanimously recommended that Cracker Barrel shareholders vote AGAINST the non-binding advisory proposals publicly made by Biglari Capital and its affiliates requesting Cracker Barrel’s Board to immediately pursue all potential extraordinary transactions, including the sale of the company, and take any action necessary to amend the Tennessee Business Corporation Act to permit Biglari Capital to engage in an extraordinary transaction with the company. In recommending shareholders vote AGAINST the non-binding advisory proposals, all three advisory firms voiced their support for Cracker Barrel’s current strategy and agreed that seeking an immediate sale of the company is not in the best interests of the company's shareholders in light of current market conditions and the company's sustained strong performance. Commenting on the endorsement for the current strategy, Sandra B. Cochran, Cracker Barrel's President and CEO, stated: “We are extremely pleased that ISS, Glass Lewis and Egan-Jones continue to support our current strategy and agree with our recommendation that our shareholders vote AGAINST both of the proposals. We continue to believe that execution of the current operational and strategic plan remains the best means for creating long-term value for all of our shareholders.”
April 10, 2014
16:45 EDTVARVarian Medical settles patent dispute with University of Pittsburgh
Subscribe for More Information
10:00 EDTALKSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:55 EDTALKSAlkermes upgraded to Buy from Neutral at Mizuho
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use